Osaic Holdings
INTS icon

Osaic Holdings’s Intensity Therapeutics INTS Stock Holding History

Osaic Holdings’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18K Buy
+200
New +$1.63K ﹤0.01% 7216
2024
Q1 		– Sell
-160
Closed -$34.3K – 7298
2023
Q4 		$34.3K Buy
160
+80
+100% +$8.42K ﹤0.01% 5139
2023
Q3 		$7.94K Buy
+80
New +$11.1K ﹤0.01% 6059

Other funds holding INTS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.18B AUM 18.43% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings's INTS Position: Q1 2026 in Review

Osaic Holdings opened a new position in Intensity Therapeutics (INTS) in Q1 2026: 200 shares worth $1.18K. The stake represents ﹤0.01% of the portfolio and ranks #7216 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in INTS as recently as Q4 2023.

Osaic Holdings first reported a position in INTS in Q3 2023 and has held it in 3 quarters since. The position peaked at $34.3K in Q4 2023. 13 funds tracked by Wall St. Rank hold INTS as of Q1 2026.

  • Osaic Holdings held 200 shares of Intensity Therapeutics worth $1.18K as of Q1 2026.
  • Intensity Therapeutics was a new Osaic Holdings position in Q1 2026.
  • Intensity Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7216 holding.
  • Osaic Holdings first reported a position in Intensity Therapeutics in Q3 2023 and has held it in 3 quarters since.
  • Osaic Holdings's Intensity Therapeutics position peaked at $34.3K in Q4 2023.
  • 13 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.